Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice (Q38332272)

2 September 2017

title

Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice (English)

1 reference

2 September 2017

0 references

1 reference

1 reference

Y Liang

1

1 reference

2 September 2017

M Lubkin

2

1 reference

2 September 2017

H Sheng

3

1 reference

2 September 2017

P W Scislowski

4

1 reference

2 September 2017

A H Cincotta

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

Biochimica et Biophysica Acta

2 September 2017

published in

1 reference

2 September 2017

volume

1405

1 reference

2 September 2017

issue

1-3

1 reference

2 September 2017

page(s)

1-13

1 reference

The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Insulin treatment improves glucose-induced insulin release in rats with NIDDM induced by streptozocin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Chronic effect of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic beta-cell line (beta HC9).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Laboratory animals exhibiting obesity and diabetes syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

The effect of artificial sweetener on insulin secretion. II. Stimulation of insulin release from isolated rat islets by Acesulfame K (in vitro experiments)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Content of CoA-esters in perifused rat islets stimulated by glucose and other fuels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Radiometric oil well assay for glucokinase in microscopic structures.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Signal transduction in isolated islets from the ob/ob mouse: enhanced sensitivity of protein kinase C to stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Bromocriptine and insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Modulation of insulin secretion and 45Ca2+ efflux by dopamine in glucose-stimulated pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Bromocriptine/SKF38393 ameliorates islet dysfunction in the diabetic (db/db) mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Leptin normalizes the impaired response of proinsulin mRNA to long chain fatty acids in heterozygous Zucker diabetic fatty rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Heterogeneity in glucose sensitivity among pancreatic beta-cells is correlated to differences in glucose phosphorylation rather than glucose transport.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Upregulated Hexokinase Activity in Isolated Islets from Diabetic 90% Pancreatectomized Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Glucose-6-phosphatase activity in islets from ob/ob and lean mice and the effect of dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Adenovirus-mediated expression of the catalytic subunit of glucose-6-phosphatase in INS-1 cells. Effects on glucose cycling, glucose usage, and insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Transcriptional regulation of hexokinase I mRNA levels by TSH in cultured rat thyroid FRTL5 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Cyclic AMP and fatty acids increase carnitine palmitoyltransferase I gene transcription in cultured fetal rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Paradoxical glucagon release in obese hyperglycemic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Effect of diethyldithiocarbamate and other agents on mice with the obese-hyperglycemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4889%2898%2900092-5

7 January 2021

10.1016/S0167-4889(98)00092-5

Identifiers

DOI

1 reference

2 September 2017

1 reference